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This study describes the isolation of a major portion of the gene for nuclear factor I (NFI) including its S-flanking region 
with transcriptional start sites. We screened a porcine liver, genomic DNA library in phage EMBL3A with synthetic 
oligonucleotides derived from tryptic and cyanogen-bromide peptide sequences obtained from purified NFI protein. The 
NFI gene is present as a single copy in porcine DNA. 
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1. INTRODUCTION 
Nuclear factor I (NFI) was originally identified 
as a factor required for the efficient initiation of 
adenovirus type 215 DNA replication [l]. Subse- 
quently it was shown to mediate its effect by 
binding to a dyad-symmetry binding site within the 
102 bp long inverted terminal repetition of the 
viral DNA [2]. Additional binding sites have been 
found within the genomes of other DNA viruses 
[3,4] and in cellular, chromosomal DNA [5-71. It 
was pointed out by Jones et al. [8] that one half site 
of the consensus sequence TGG(A/C)NKCAA 
represents the CCAAT box, identified as a pro- 
moter element in a variety of eukaryotic promoters 
[9,10]. This observation suggests a similarity or 
even an identity of NFI with the CCAAT-element 
binding transcription factor. However, the situa- 
tion appears considerably more complex. Chodosh 
et al. [l l] have shown recently that at least three 
different CCAAT-binding proteins with different, 
non-overlapping specificities to various CCAAT 
elements can be isolated from HeLa cell nuclear 
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extracts. In addition, Meisterernst et al. [12] have 
demonstrated that a highly purified NFI prepara- 
tion from porcine liver does not bind with signifi- 
cant equilibrium binding constants to CCAAT 
elements from various eukaryotic promoter 
elements. Therefore it remains unclear whether 
there are a number of distinct CCAAT proteins 
derived from different genes, or whether they 
represent a family of closely related, but func- 
tionally slightly different, proteins derived from a 
single transcriptional unit by differential splicing 
events and/or different post-translational modifi- 
cations. 
As a prerequisite for further functional studies 
of NFI we cloned the corresponding gene. 
2. MATERIALS AND METHODS 
NFI was purified from freshly prepared porcine liver nuclear 
extracts [12,13]. Approximately 2Opg (500 pmol) of a 
homogeneous NFI preparation was lyophilised and treated in 
70% formic acid with a 50-fold molar excess of cyanogen 
bromide (0.5 mg/ml) in the dark at room temperature for 1 h. 
Trypsin digestion of the cyanogen bromide-cleaved NFI was 
performed in 0.1 M ammonium hydrogen carbonate at a 
protein concentration f 30 ng/Fl after addition of l/40 of the 
probe weight of trypsin (0.5 ng). After digestion at 37°C for 
18 h the peptide mixture was acidified to 0.1% trifluoroacetic 
acid and separated by HPLC reversed-phase chromatography 
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GTTTTATTGG AACACTGTCA 
ACAGTGCAGA GTGGAGCGGT 
GTACTTTTAA AGTTTGCTGA 
CATTCTACTA TCCTCAGTTT 
GACCCTCATC TTGTCCTACC 
GGCCCGCGCC TGCCATGTGG 
Pepride 3 
CAGCCATCAC TTACATGTCC TCTGTGACCA GTCTTACACT 
GCAACAGAG ACTGAAATAC TCATTATTTG ATTCTTTATG 
CCCCAGT?$kAGGCAGA GAATGGGTCC ATGCTACCCC 
TCCCCATCTG GX!?GGT CCCCATCAGA CTCTACCTGG 
r,l, 
Tdr"A?;ijTTGG GTTCAGGAC AGTCCATAAA CGGCTGCCTT . . . . . . . . . . . 
TCCAAGCCTC TTGTTTCCCC ATCTGGACA ATG GGC TCT 
MET Gly Ser 
A TGAACTTCGGCGGGGCCCCTTCTGGCCTCATTTTCCCCAAGAGGTAGAG fzz%%iE 
yPSt17 
GGCTCTGCAGAGGCCCCCTGAACACCTCTGCCCTCCCTCCCTCTAGTGGGTCTGCATGGGGCCCC 
TGCGGCCTCAGTCTTCTGGGCCGGGCAGTGGGTCCACGGACCCAGCACCTCCTGACCTCTGGCTT 
Peptide 3 
CTCGCGCCCGCAG GAT GAG TTC CAC CCA TTC ATC GAG GCG CTG CTG CCT CAC 
Asp Glu Phe His Pro Phe Ile Glu Ala Leu Leu Pro His 
PSI1 
GTC CGC GCC TTC GCC TAC ACC TGG TTC AACG CA6 GCG CGG AAG CGC 
Val Arg Ala Phe Ala Tyr Thr Trp Phe Asn Leu Gln Ala Arg Lys Arg 
AAG TAC TTC AAG AAG CAT GAG AAG CGG ATG TCA AAA GAT GAG GAG CGG 
Lys Tyr Phe Lys Lys His Glu Lys Arg Met Ser Lys Asp Glu Glu Arg 
Peplide 4 
GCG GTG AAG GAC GAG CTG CTG GGC GAG AAG GCC GAG GTC AAG CAG AAG 
IAla Val Lys Asp Glu Leu Leu Glyl Glu Lys Ala Glu Val Lys Gln Lys 
TGG GCG TCG CGG CTG CTG GCC AAG CTG CGC AAG GAC ATC CGG CCC GAA 
Trp Ala Ser Arg Leu Leu Ala Lys Leu Arg Lys Asp Ile Arg Pro Glu 
____________________-____ 
TGC CGC GAG GAC TTT GTG CTG GCC ATC ACC GGC AAG AAG GCG CCA GGC' __________________________ 
Cys Arg Glu Asp Phe Val Leu Ala Ile Thr Gly Lys Lys Ala Pro Gly 
Peotide 2 -~---~--,~--~~--,~-,~~-,-_~,--,_-~,-_~,~~~~~~~~~~~~~~~~~ 
T.fX_ GTG LX_ TCC A?C_ CCC J-AC_ CbG AA!2 GGC AJiG_ BTG 
Cys Val Leu Ser Asn Pro Asp Gln Lys Gly Lys Met 
Prntin. 7 --c-:-i. ____ _____________ ______ _ __________ _ 
~TE-ES~~G.~-E~XZ~ GAC AAG GTG TGG CGG CTG GAC ~TG_GT_C_&PTG_~T~: 
Cys Leu Arg Gln Ala Asp Lys Val Trp Arg Leu Asp Leu Val Met Val 
AGC ACC GAC GGC GAG CGC CTG 
Ser Thr Asp Gly Glu Arg Leu 
GTC AAG GCG GCA CAG TGC GGC CAC CCG GTG CTC TGC GTG CAG CCA CAC 
Val Lys Ala Ala Gln Cys Gly His Pro Val Leu Cys Val Gln Pro His 
CAC ATT GGG GTG GCG GTC AAG'GAG CT6 GAT CTC TAC CTG GCC TAC TTC 
His Ile Gly Val Ala Val Lys Glu Leu Asp Leu Tyr Leu Ala Tyr Phe 
GTG CGC GAG CGA 
$ 
T GAG GCG GGG CGT GCA CGT GGA CGC GGG TCT GAC 
Val Arg Glu Arg y Glu Ala Gly Arg Ala Arg Gly Arg Gly Ser Asp 
GGC CGA GAG GGG ATG CGC CGG GCA TCG CAG AGC GGA CGT CCT GGG GAA 
Gly Arg Glu Gly Met Arg Arg Ala Ser Gln Ser Gly Arg Pro Gly Glu 
AGT GGA CCC GCA GGC CTG AGG GAC CAG GCT GGC ACG CGC AGC CTG GGG 
Ser Gly Pro Ala Gly Leu Arg Asp Gln Ala Gly Thr Arg Ser Arg Gly 
TGG GCA GGC TGA CCTATAAGAGGTCTGAGGGCGGAGGCTTGTCCACCCAAGGTGGTCTACC 
Trp Ala Gly END 
CAGCGGGGAGGCTTGCTCACACAAGGTACCAGCAAGGAGGCTGGTGC 
AGGTTGTCTGAGGGGGG~G~GCTGCACTGAGAGGGTCAGAGCAGGGAAGTGGGCCTATGCTGG 
GGTCGGAAGG-- 
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on LiChrospher columns at 0.5 ml/mm in a gradient of O-60% 
acetonitrile in 0.1% trifluoroacetic acid. Sequences were ob- 
tained by automated Edman degradation on an Applied 
Biosystems model 470A sequencer as described [14]. 
Phage from an EMBL3A library of porcine liver genomic 
DNA were plated at a density of 50000 plaques per 15 cm petri 
dish. After transfer onto nitrocellulose filters (Schleicher and 
SchiIll BA85) they were marked and prepared for hybridization 
as described [15]. The following three probes were used: 
Probe 1: 5 ‘ -AT~CTGTT&4AGGG~AT&C~CTGGA-3 ’ 
The corresponding CNBr-peptide (Pl) sequence was: 
ILFKGIPLE. 
Probe 2: 5’-GTCCCAGGCGCCACACCTTGTCAGCCTGC- 
CGCAGGCAGTCAATGCGCCG-3’ 
The corresponding CNBr-peptide (P2) sequence was: 
RRIDCLRQADKVWRLD. 
Probe 3: 5 ‘-GC~TCAAT&AANGG~TG&%A$TCATC-3’ 
5 ’ -GC:TCTAT&AANGG~TG&4A~TCATC-3 ’ 
The corresponding tryptic peptide (P3) sequence was: 
LTQDEFHPFIEALLP. 
Screening with mixed probes 1 and 3 (l-2 pmol each of 32P- 
labelled oligonucleotide) was performed according to [15] at a 
temperature of 42’C; long probe 2 was hybridized in 1 x SSC, 
1 x Denhardt’s solution and 100 pg/ml tRNA (yeast) at 42°C. 
Washing was performed for 10 min at room temperature, 1 x 
10 min at 50°C and 1 x 10 min at 60°C in 6 x SSC for probes 
1 and 3, and in 1 x SSC for long probe 2. 
Double-stranded DNA sequencing was performed as de- 
scribed [ 151. Procedures for the isolation of total RNA and of 
mRNA were taken from [15]. Southern blots were performed 
according to [15] and Northern blots according to [16]. 
Transcript mapping by an Si nuclease protection assay was per- 
formed according to [17]. 
3. RESULTS 
NFI was purified from porcine liver crude 
nuclear extracts by various chromatography steps 
including DEAE-cellulose, MonoQ anion-ex- 
change chromatography and sequence-specific 
DNA-affinity chromatography [121. After enrich- 
ment to a factor of approx. 100000, the protein 
preparation migrated in SDS-polyacrylamide gel 
electrophoresis as a single molecular species with a 
molecular mass of 36 kDa [12]. Since the amino- 
terminus of the protein was blocked, it was sub- 
jetted to CNBr and/or trypsin digestion in order to 
obtain partial peptide sequences by sequential Ed- 
man degradation. Synthetic oligonucleotides were 
derived either as mixed or as long probes; in the 
latter case they were optimized according to 
human codon usage [ 181. Three probes (see section 
2) were employed to screen a porcine genomic 
library in phage EMBL3A. Clones which lit up 
simultaneously with all these probes were enriched 
and rescreened. Out of 1.2 x lo6 clones screened a 
total of six were identified which hybridized to all 
three probes. All clones share only a number of 
restriction fragments (not shown) and thus appear 
to be independent isolates of the same genomic se- 
quence. 
The DNA sequence of a 3.7 kb BgflI fragment 
was determined from a set of HpaII subclones in 
pUC12. A selected portion (1500 bp) of this se- 
quence is shown in fig.1. It contains the sequence 
of the three probes used for the original screening 
and a sequence obtained from an additional tryptic 
peptide (P4; AVKDELL). All these sequences are 
present in a single long reading frame extending 
from positions 623 to 1301, corresponding to 224 
codons. The three N-terminal amino acids of pep- 
tide P3 however could not be detected in this 
reading frame. Instead, they were found together 
with a preceding arginine residue (expected from 
the tryptic origin of this peptide) in a reading 
frame extending between positions 350 and 430. 
The only Met codon in this reading frame is 
situated at position 410, defining an N-terminal se- 
quence of seven amino acids. The reading frame in 
this region is therefore interrupted by an intron of 
192 bp between positions 431 to 622. This intron 
itself is defined by a tryptic peptide which overlaps 
the two splice sites. 
The remote possibility of the four N-terminal 
amino acids to occur elsewhere in the genome, i.e. 
further upstream in this genomic DNA sequence, 
was ruled out by Si nuclease protection assays 
(fig.2) which place the transcriptional start site of 
the gene at positions 347 and 351, i.e. immediately 
upstream of the expected Met codon discussed 
above. 
Fig. 1. Nucleotide sequence from the porcine NFI gene. Arrows point to the location of transcriptional start sites. Boxes mark the four 
peptides obtained from NFI by tryptic and/or cyanogen-bromide digestion. The vertical bar indicates the putative splice site between 
exons 2 and 3. Dotted boxes enclose putative CAAT or TATA boxes, the dashed box a stretch of DNA between positions 880 and 
1013 with 67% identity to the chicken histone 2B gene. A potential NFI site in the 5’-flanking region is underlined. 
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Fig.2 Mapping of transcriptional start sites through the SI nuclease protection assay. A schematic representation of the experiment 
in which a fully labelled, 280 bp XbaI/PstI fragment from the expected 5 ‘-flanking region was hybridized to cytoplasmic RNA from 
porcine liver is shown in the upper part. The lower part displays an autoradiograph of the polyacrylamide gel which separated the 
products remaining after SI nuclease digestion. Size markers are the four reaction products from-a sequencing reaction run on the 
same gel. Product sizes are 81 and 85 bp, respectively. 
The sequence described in this communication 
covers a total of 231 amino acids and thus cannot 
represent he entire protein (36 kDa). We thus pro- 
pose the existence of at least one additional intron 
and exon region. Considering the known consen- 
sus splice region sequence (GTA/GAGT; [16]) as 
well as the fact that the following sequence stretch 
contains multiple stop codons in all three reading 
frgmes we assume at present that the 5’-splice site 
for this intron is located at position 1154 (fig.1; 
vertical bar). This leaves a total of 184 amino acids 
identified so far for the NFI protein. We are cur- 
rently searching our EMBL3A library for the lack- 
ing 3 ‘-portion of the NFI gene which should 
comprise at least an additional 150 codons. 
A 1.3 kb PstI fragment covering most of exon 2 
and extending into intron 2 and a 279 bp &a11 
fragment from within exon 2 were used as probes 
in Southern and Northern blot analyses, respec- 
tively. As shown in the autoradiograph of the 
Southern blot (fig.3), we detected only one single 
fragment in porcine DNA after digestion with 
several restriction enzymes which have no cleavage 
site in the probe DNA sequence. In Northern blots 
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Fig.3. Genomic Southern blot analysis of the porcine NFI gene. 
The probe was a 1.3 kb PstI fragment covering parts of exon 
2 and intron 2. 
of porcine liver poly(A) selected cytoplasmic RNA 
(f&.4), a strong band of 4.5 and two minor bands 
of 6.8 and 8 kb could be detected. 
4. DISCUSSION 
This paper describes the DNA sequence of a 
genomic clone from porcine liver DNA which con- 
tains a significant portion of the porcine NFI gene. 
This conclusion is mainly confirmed by the fact 
that the sequences of four cyanogen-bromide and 
tryptic peptides obtained from a homogeneous and 
active NFI preparation could be identified in a 
single, long reading frame covering more than half 
of the expected protein sequence. As confirmed by 
Si nuclease protection assays, our clone also con- 
tains the transcriptional start site and 5 ‘-flanking 
regions of the NFI gene. 
The following points should be raised. Firstly, 
the putative promoter region not only contains the 
expected TATA and CC&XT-box elements but, in 
addition, reasonably strong NFI binding sites (cf. 
Fig.4. Northern blot analysis of cytoplasmic poly(A) containing 
RNA from porcine liver. In addition to a stronger band of 
4.5 kb, two minor bands at 6.8 and 8 kb are clearly visible. The 
probe was a 279 bp HpaII fragment extending from position 
565 to position 844. 
fig.1). It remains to be seen, whether these are in- 
volved in transcriptional regulation of this gene, 
i.e. in autoregulation. Secondly, the larger of the 
two exons contains a stretch of DNA between posi- 
tions 880 and 1013 which displays a 65% degree of 
identity with the chicken histone H2B gene [19]. 
Since this homology does not extend to the protein 
level its significance remains unknown. Thirdly, 
we want to emphasize that the 5’-splice site of the 
first intron, which is defined by an overlapping 
cyanogen-bromide peptide, contains the dinucleo- 
tide TG rather than GT as described for consensus 
5 ‘-splice sites [20]. The significance of this varia- 
tion is not known. Finally, we have identified at 
least three mRNA species in Northern blots of 
31 
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total porcine liver cytoplasmic RNA, indicating 
that expression of this single gene might be 
regulated by differential splicing. This in turn may 
result in the formation of functionally different 
proteins acting, for example, as NFI or as CCAAT 
binding factors. Work is in progress in our 
laboratory to address this question. 
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